Geneart AG
Records under this name other than the patents Geneart AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,046,953 | High Efficiency, Small Volume Nucleic Acid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 10,519,439 | High Efficiency, Small Volume Nucleic Acid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 10,745,695 | Tal-Effector Assembly Platform, Customized Services, Kits and Assays Formerly held In force · High confidence | In force | High confidence | |
| US 12,209,239 | High Efficiency, Small Volume Nucleic Acid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 11,041,068 | Solid support Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D664,043 | Packaging container for bottles Term ended Term ended Jul 24, 2026 · From the USPTO record | Term ended | Term ended Jul 24, 2026 | From the USPTO record |
| US 8,691,533 | Inducible gene expression Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 8,287,881 | Synthetic gagpol genes and their uses Term ended Term ended Jul 29, 2024 · From the USPTO record | Term ended | Term ended Jul 29, 2024 | From the USPTO record |
| US 7,332,588 | Genome of the HIV-1 inter-subtype (C/B) and use thereof Term ended Term ended Nov 4, 2022 · From the USPTO record | Term ended | Term ended Nov 4, 2022 | From the USPTO record |
| US 7,323,557 | Genome of the HIV-1 inter-subtype (C/B') and use thereof Term ended Term ended Nov 16, 2020 · From the USPTO record | Term ended | Term ended Nov 16, 2020 | From the USPTO record |